Send this to a friend

Sunovion finds positive results in schizophrenia study

Marlborough biopharmaceutical company Sunovion says it has found positive results from a study of a treatment for schizophrenia.
Sunovion said patients with adult schizophrenia treated with the proposed new drug showed statistically significant and clinically meaningful improvement compared to a placebo after four weeks of treatment.
The company plans to advance the development of the medicine as quickly as possi ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media